Dr. Cohen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1000 FivePoint
Irvine, CA 92618Phone+1 949-671-4673Fax+1 949-777-6703
Summary
- Dr. Joshua Cohen is an associate professor in gynecologic oncology with City of Hope Cancer Center. He received his medical degree from Northwestern University Feinberg School of Medicine and has been in practice 11 years. Dr. Cohen completed his residency at the University of California San Francisco and his fellowship with the University of California Los Angeles/Cedars-Sinai Medical Center. He specializes in general gynecology and gynecologic oncology and is experienced in general obstetrics and gynecology, hysterectomy, general gynecology, gynecologic oncology, and trachelectomy. He is medical director of the Gynecologic Cancer Program at City of Hope Orange County.
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Gynecologic Oncology, 2011 - 2014
- University of California (San Francisco)Residency, Obstetrics and Gynecology, 2007 - 2011
- Northwestern University The Feinberg School of MedicineClass of 2007
- National Cancer InstitutePost-Doctoral Fellowship, 2005 - 2006
Certifications & Licensure
- CA State Medical License 2008 - 2026
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Clinical Trials
- Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Ovarian, Fallopian Tube, or Peritoneal Cancer (GLORIOSA) Start of enrollment: 2022 Dec 27
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- Combining the prognostic role of age with molecular advances in the understanding of endometrial cancer.Rosemary N Senguttuvan, Joshua G Cohen
The Lancet. Oncology. 2024-06-01 - Integrating social care into gynecologic oncology: Identifying and addressing patient's social needs.Katherine Cotangco, Elizabeth Pineda, Veda Hingarh, Natsai C Nyakudarika, Joshua G Cohen
Gynecologic Oncology. 2023-12-01 - DEDD Motif Mutation Confers Hypermutation in Endometrial Cancer and Durable Response to Pembrolizumab.Christina Hsiao Wei, Edward Wenge Wang, Lingzi Ma, Yajing Zhou, Li Zheng
Cancers. 2023-11-30
Press Mentions
- New Cervical Cancer Treatment Improves Survival Rates, Clinical Trial ShowsOctober 21st, 2024
- The #1 Lifestyle Change That Can Actually Lower Your Reproductive Cancer Risk, According to OncologistsOctober 2nd, 2024
- New Study Suggests Ovarian Cancer Can Be Detected Early: These 4 Symptoms Are KeySeptember 4th, 2024
Professional Memberships
- Member
- Member
- Member
External Links
- Work Informationhttps://www.cityofhope.org/joshua-g-cohen
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: